HomeCompareHERB vs MRK

HERB vs MRK: Dividend Comparison 2026

HERB yields 12500.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HERB wins by $498747976996367872.00M in total portfolio value
10 years
HERB
HERB
● Live price
12500.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$498747976996367872.00M
Annual income
$491,020,681,003,619,800,000,000.00
Full HERB calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — HERB vs MRK

📍 HERB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHERBMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HERB + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HERB pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HERB
Annual income on $10K today (after 15% tax)
$1,062,500.00/yr
After 10yr DRIP, annual income (after tax)
$417,367,578,853,076,800,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, HERB beats the other by $417,367,578,853,076,800,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HERB + MRK for your $10,000?

HERB: 50%MRK: 50%
100% MRK50/50100% HERB
Portfolio after 10yr
$249373988498183936.00M
Annual income
$245,510,340,501,809,900,000,000.00/yr
Blended yield
98.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HERB
No analyst data
Altman Z
0.8
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HERB buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHERBMRK
Forward yield12500.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$498747976996367872.00M$57.7K
Annual income after 10y$491,020,681,003,619,800,000,000.00$10,113.78
Total dividends collected$498235517183739840.00M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HERB vs MRK ($10,000, DRIP)

YearHERB PortfolioHERB Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,260,700$1,250,000.00$11,213$373.04+$1.25MHERB
2$148,626,986$147,278,037.38$12,667$512.06+$148.61MHERB
3$16,386,101,622$16,227,070,746.70$14,439$708.14+$16386.09MHERB
4$1,689,525,624,319$1,671,992,495,582.84$16,640$988.16+$1689525.61MHERB
5$162,924,168,596,046$161,116,376,178,025.50$19,432$1,394.07+$162924168.58MHERB
6$14,694,663,924,503,782$14,520,335,064,106,012.00$23,057$1,992.90+$14694663924.48MHERB
7$1,239,682,670,110,485,000$1,223,959,379,711,266,000.00$27,889$2,894.79+$1239682670110.46MHERB
8$97,827,968,310,781,350,000$96,501,507,853,763,130,000.00$34,518$4,286.29+$97827968310781.31MHERB
9$7,221,771,955,839,384,000,000$7,117,096,029,746,848,000,000.00$43,912$6,494.35+$7221771955839384.00MHERB
10$498,747,976,996,367,840,000,000$491,020,681,003,619,800,000,000.00$57,714$10,113.78+$498747976996367872.00MHERB

HERB vs MRK: Complete Analysis 2026

HERBStock

YaSheng Group, through its subsidiaries, designs, develops, manufactures, and markets farming and sideline products; chemical materials and products; textiles; construction materials; and livestock and poultry products primarily in the People's Republic of China. It cultivates, processes, markets, and distributes various food and agro-byproducts. The company's products include cotton, corns, barley, wheat, flax, and alfalfa; vegetables comprising onions, potatoes, beet, and peas; fruits, including apples, pears, and apricots; specialty crops consisting of hops, wolfberries, cumin, hemp, and liquorices; seeds, such as black melon, sunflower, corn, hemp, and flax seeds; and eggs. It also provides construction materials, such as cement; and designs, develops, and markets new technologies related to agriculture and genetic biology. The company sells its products to food processors, supermarkets, and wholesale stores through distributors, as well as to direct customers. YaSheng Group exports its products. The company was founded in 1998 and is based in Lanzhou, the People's Republic of China. As of December 31, 2015, YaSheng Group is a subsidiary of Gansu Yasheng Salt Chemical Industrial Group, Ltd.

Full HERB Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HERB vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HERB vs SCHDHERB vs JEPIHERB vs OHERB vs KOHERB vs MAINHERB vs JNJHERB vs ABBVHERB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.